ERBB2 and carcinoma: The largest difference is between carcinomas and sarcomas, with significant differences found in the mutational frequency of TP53, PIK3CA, NRAS, ERBB2 and BRAF. Carcinomas are more variable than sarcomas in their mutational spectrum and mutational burden.